It has long been known that cooling can increase survival chances after critical illnesses, such as cardiac arrest, by reducing the risk of brain damage caused by oxygen deprivation.
QuickCool AB offers a unique, portable, quick-to-apply brain and body cooling system with a delivery method that does not impede medical procedures. The cooling process is rapidly initiated via the nasal cavity, so medical staff have clear access to the rest of the body for examinations and treatment.
The QuickCool® SYSTEM is an easy to use, portable solution for Temperature Management at 36 °C – an optimum temperature for cooling cardiac arrest patients.
Targeted Temperature Management (TTM), previously known as therapeutic hypothermia or protective hypothermia, is an active treatment to achieve and maintain a specific body temperature in a patient for a specific period in an effort to improve health outcomes.